OptraSCAN

Digital Pathology Scanners & AI Diagnostics Platform

San Jose, United States · Founded 2017 · $30.0M raised

Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$30.0M
Last Round
$30.0M Series BNov 2024
Rounds
1

About

OptraSCAN offers an end-to-end digital pathology platform with high-throughput, high-resolution whole-slide imaging scanners for clinical laboratories, research institutions, and telepathology networks. Its AI-powered diagnostic analysis uses validated deep learning for cancer detection, grading, immunohistochemistry quantification, and biomarker discovery across tissue types. The company reports more than 200 labs and institutions worldwide, CE marking, ISO 13485 certification, and HIPAA compliance.

Summary

OptraSCAN is an Artificial Intelligence company based in San Jose, United States, founded in 2017. It has raised $30.0M in total across 1 round, most recently a $30.0M Series B round in Nov 2024.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BNov 2024
$30.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OptraSCAN on Indexed.vc
<a href="https://indexed.vc/companies/optrascan"><img src="https://indexed.vc/api/badge/company/optrascan" alt="OptraSCAN on Indexed.vc" width="260" height="76" /></a>